Perphenazine Tablet, Film Coated
FDA Label NDC 0904-6599

24 label sections · Submitted to the FDA by Major Pharmaceuticals · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Perphenazine (NDC 0904-6599). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, description, actions, pharmacokinetics, indications and usage, contraindications, warnings, neuroleptic malignant syndrome (nms), and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

MAJOR®

NDC 0904-6599-61

Unit Dose

Perphenazine

Tablets, USP

2 mg

100 TABLETS (10 x 10)

Rx only

2mg Carton Label (3419fc97 71b9 4232 A501 Affe4e2c7a7f 02)

2mg Carton Label (3419fc97 71b9 4232 A501 Affe4e2c7a7f 02)

MAJOR®

NDC 0904-6600-61

Unit Dose

Perphenazine

Tablets, USP

4 mg

100 TABLETS (10 x 10)

Rx only

4mg Carton Label (3419fc97 71b9 4232 A501 Affe4e2c7a7f 01)

4mg Carton Label (3419fc97 71b9 4232 A501 Affe4e2c7a7f 01)

MAJOR®

NDC 0904-6601-61

Unit Dose

Perphenazine

Tablets, USP

8 mg

100 TABLETS (10 x 10)

Rx only

8mg Carton Label (3419fc97 71b9 4232 A501 Affe4e2c7a7f 00)

8mg Carton Label (3419fc97 71b9 4232 A501 Affe4e2c7a7f 00)

* Please review the disclaimer below.